Published in Neuroscience on January 01, 2000
Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev (2010) 2.13
Early menopausal hormone use influences brain regions used for visual working memory. Menopause (2010) 1.67
High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People. Biol Psychiatry (2014) 1.54
Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here? Horm Behav (2008) 1.39
Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men. Psychoneuroendocrinology (2010) 1.16
Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10
Chronic treatment with estrogen receptor agonists restores acquisition of a spatial learning task in young ovariectomized rats. Horm Behav (2009) 1.07
Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. J Affect Disord (2010) 1.01
Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals. Front Physiol (2012) 1.01
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev (2015) 0.95
Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective. Front Neurosci (2014) 0.94
Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia. Schizophr Bull (2008) 0.91
The amygdala: an agent of change in adolescent neural networks. Horm Behav (2013) 0.91
Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. Curr Alzheimer Res (2008) 0.87
Where and what is the paralaminar nucleus? A review on a unique and frequently overlooked area of the primate amygdala. Neurosci Biobehav Rev (2011) 0.84
Age differences in perception and awareness of emotion. Neurobiol Aging (2007) 0.83
Sex steroid hormones matter for learning and memory: estrogenic regulation of hippocampal function in male and female rodents. Learn Mem (2015) 0.80
Aberrant neurocognitive processing of fear in young girls with Turner syndrome. Soc Cogn Affect Neurosci (2012) 0.80
Estrogen modifies arousal but not memory for emotional events in older women. Neurobiol Aging (2007) 0.79
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review. Front Behav Neurosci (2016) 0.79
Does puberty mark a transition in sensitive periods for plasticity in the associative neocortex? Brain Res (2016) 0.77
Hormone therapy does not modify emotion-induced brain activity in older women. Horm Behav (2009) 0.77
FDG-PET analysis of amygdalar-cortical network covariance during pre- versus post-menopausal estrogen levels: potential relevance to resting state networks, mood, and cognition. Neuro Endocrinol Lett (2008) 0.77
Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses. Psychiatry Res (2015) 0.76
Regulation of Estrogen Receptor α Expression in the Hypothalamus by Sex Steroids: Implication in the Regulation of Energy Homeostasis. Int J Endocrinol (2015) 0.75
Impact of Sex and Menopausal Status on Episodic Memory Circuitry in Early Midlife. J Neurosci (2016) 0.75
Prenatal stress-immune programming of sex differences in comorbidity of depression and obesity/metabolic syndrome. Dialogues Clin Neurosci (2016) 0.75
A Review of the Status of Brain Structure Research in Transsexualism. Arch Sex Behav (2016) 0.75
Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1. Transl Psychiatry (2016) 0.75
Primer on certain elements of medical decision making. N Engl J Med (1975) 6.28
Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology (1996) 2.38
Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke (1998) 1.95
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr (1995) 1.81
Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol (1998) 1.78
Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab (2002) 1.55
Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant (1998) 1.53
Tissue-interface pressures on three different support-surfaces for trauma patients. Injury (2005) 1.47
Continuous arteriovenous haemoperfusion (CAVHP) for treatment of paraquat poisoning. Nephrol Dial Transplant (1992) 1.41
Gulliver G-100 - A new device to evaluate daily growth measurement in comparison with Harpenden stadiometer. Horm Res (1999) 1.40
European Council of Legal Medicine (ECLM) accreditation of forensic pathology services in Europe. Int J Legal Med (2014) 1.40
Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis. J Rheumatol (1997) 1.39
IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia (2003) 1.37
MRI findings in Hirayama's disease: flexion-induced cervical myelopathy or intrinsic motor neuron disease? J Neurol (1999) 1.36
The Nuclear Receptor Resource: a growing family. Nucleic Acids Res (1998) 1.34
Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab (2000) 1.29
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol (2008) 1.28
Effect of local low-dose thrombolysis on clinical outcome in acute embolic renal artery occlusion. Radiology (1993) 1.27
The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci (2010) 1.27
Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol (2001) 1.25
Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res (1998) 1.24
Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med (2000) 1.23
The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23
Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations. Clin Pharmacokinet (1993) 1.22
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res (1998) 1.17
Central venous catheter-induced delayed hydrothorax via progressive erosion of central venous wall. Minerva Anestesiol (2010) 1.15
Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. Neuroradiology (2000) 1.14
Human pituitary gonadotropin index. I. Standardized LRH test criteria for evaluation of functional amenorrhea. J Clin Endocrinol Metab (1975) 1.12
Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur J Neurosci (2003) 1.12
Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology (2000) 1.11
Effectiveness of treatments of depression in older ambulatory patients. Arch Intern Med (1998) 1.10
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology (2000) 1.10
ERK5 signalling in prostate cancer promotes an invasive phenotype. Br J Cancer (2011) 1.10
Mesolimbic gender differences in peptide CART mRNA expression: effects of cocaine. Neuroreport (1999) 1.10
Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy (2002) 1.07
Similarities in the control of the speech articulators and the limbs: kinematics of tongue dorsum movement in speech. J Exp Psychol Hum Percept Perform (1983) 1.06
Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle. J Pediatr Endocrinol Metab (2003) 1.06
Structure, chromosomal localization, and brain expression of human Cx36 gene. J Neurosci Res (1999) 1.04
The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics (2005) 1.04
Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia (1999) 1.03
The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. Int J Obes Relat Metab Disord (2003) 1.02
Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology (2001) 1.02
Kinetics of ceftazidime during plasmapheresis. Eur J Clin Pharmacol (1987) 1.02
Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse (2000) 1.00
Transcription termination factor Rho is essential for Micrococcus luteus. J Bacteriol (1997) 1.00
Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses. Eur J Clin Pharmacol (1991) 0.99
Gonadotropin-releasing hormone neurons express estrogen receptor-beta. J Clin Endocrinol Metab (2007) 0.99
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience (2003) 0.99
The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J Neurochem (2000) 0.98
Mechanosensitivity of voltage-gated calcium currents in rat anterior pituitary cells. J Physiol (1994) 0.97
Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Clin Neuropharmacol (1994) 0.97
Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab (2006) 0.97
Treatment of pelvic abscesses: value of one-step sonographically guided transrectal needle aspiration and lavage. AJR Am J Roentgenol (1995) 0.96
Surgical removal and immediate reattachment of coronal fragment embedded in lip. Dent Traumatol (2006) 0.96
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (1996) 0.96
Pharmacokinetics of gabapentin in subjects with various degrees of renal function. Clin Pharmacol Ther (1994) 0.96
Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. Brain Res Bull (2001) 0.94
Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum (1996) 0.94
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles. Neurobiol Dis (2000) 0.93
Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device. Horm Res (1999) 0.93
Human pituitary gonadotrophin index. II LHRH test and clomiphene response before and after LHRH stimulation. Clin Endocrinol (Oxf) (1976) 0.92
Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport (1999) 0.92
Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy. J Neurol (2001) 0.92
Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res (1998) 0.92
Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro. Anticancer Res (2001) 0.91
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Cerebral potentials preceding unilateral and simultaneous bilateral finger movements. Electroencephalogr Clin Neurophysiol (1979) 0.91
Dietary fat intakes in infants and primary school children in Germany. Am J Clin Nutr (2000) 0.90
The flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17beta-estradiol. Brain Res Mol Brain Res (1999) 0.89
Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat (2000) 0.89
[Psychosocial situation of married couples prior to artificial insemination with donor sperm]. Geburtshilfe Frauenheilkd (1984) 0.89
Distribution of an orphan G-protein coupled receptor (JP05) mRNA in the human brain. Brain Res (2001) 0.89
DR2-negative narcolepsy. Lancet (1986) 0.89
Manufacture of metal microelectrodes with the scanning electron microscope. IEEE Trans Biomed Eng (1975) 0.88
Antibiotic-impregnated versus silver-bearing external ventricular drainage catheters: preliminary results in a randomized controlled trial. Neurocrit Care (2013) 0.88
Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. J Med Toxicol (2013) 0.88
Single-dose ceftriaxone kinetics in functionally anephric patients. Clin Pharmacol Ther (1983) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population. Hum Immunol (1994) 0.87
Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Mol Psychiatry (2012) 0.87
A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol (2001) 0.87
Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization. Neuroreport (1998) 0.87
Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther (1984) 0.87
Root resorption in dental trauma: 45 cases followed for 5 years. Dent Traumatol (2003) 0.87
Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence. Brain Res Mol Brain Res (1998) 0.87
DNA typing for HLA-DPB1-alleles in German patients with systemic lupus erythematosus using the polymerase chain reaction and DIG-ddUTP-labelled oligonucleotide probes. Members of SLE Study Group. Eur J Immunogenet (1993) 0.86
Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics (1993) 0.86
Moderate hypothermia and brain temperature in patients with severe middle cerebral artery infarction. Acta Neurochir Suppl (1998) 0.86
HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics (1993) 0.86
[Iatrogenic Cushing syndrome and mutatio tarda caused by dexamethasone containing nose drops]. HNO (1999) 0.86
Reversible changes in echo planar perfusion- and diffusion-weighted MRI in status epilepticus. Neuroradiology (2000) 0.86
The Nuclear Receptor Resource Project. Nucleic Acids Res (1997) 0.86
Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res Mol Brain Res (1998) 0.86